title: Could NICE guidance on the choice of blood pressure lowering drugs be simplified?
authors.affiliation: Centre for Clinical Pharmacology, University College London, London WC1E 6JJ, UK. r.sofat@ucl.ac.uk
authors.forename: Reecha
authors.initials: R
authors.lastname: Sofat
authors.forename: Juan P
authors.initials: JP
authors.lastname: Casas
authors.forename: Anthony M
authors.initials: AM
authors.lastname: Grosso
authors.forename: Brian N C
authors.initials: BN
authors.lastname: Prichard
authors.forename: Liam
authors.initials: L
authors.lastname: Smeeth
authors.forename: Raymond
authors.initials: R
authors.lastname: MacAllister
authors.forename: Aroon D
authors.initials: AD
authors.lastname: Hingorani
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000367:Age Factors; D057911:Angiotensin Receptor Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003924:Diabetes Mellitus, Type 2 / Q000209:etiology; D004232:Diuretics / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data*; D012084:Renin-Angiotensin System / Q000187:drug effects; D012307:Risk Factors; D006113:United Kingdom
chemical_list: D000319:Adrenergic beta-Antagonists; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D004232:Diuretics